Skip to Main Content

NISH (NITAG Support Hub) 12: Whole-cell (wP) Hexavalent vaccine: Domain 5 : Health Equity

This Library Guide is a collection of useful documents & evidence on the safety, efficacy, effectiveness and impact of the whole-cell (wP) Hexavalent vaccine to support NITAG members and other policy makers throughout Africa with making evidence-based r

Keywords used

Whole Cell (wP) Hexavalent vaccine and “health equity” OR  “ethical or legal implication”

Retrieved from Google Scholar

Seinfeld, J., Sobrevilla, A., Rosales, M. L., Ibañez, M., Munayco, C., & Ruiz, D. (2024). Introduction of a hexavalent vaccine containing acellular pertussis into the national immunization program for infants in Peru: a cost-consequence analysis of vaccination coverage. BMC Health Services Research24(1), 1216. https://doi.org/10.1186/s12913-024-11684-8

Carnero Fernández, R., & Marcos Nogales, L. Vaccinating: Two Centuries and Beyond!. Ediciones Universidad de Salamanca. [Book] Open here

Reyes-Pagcatipunan, M. G., Madrid, M. A. C., Charissa-Fay-Corazon, C., Tan-Lim, C. S. C., Cabaluna, I. T. G., & Balmeo, R. B. (2023). Philippine guidelines on periodic health examination: Pediatric immunization. Pediatric Infectious Disease Society of the Philippines Journal24(1), 176-244. https://doi.org/10.56964/pidspj20232401005